Current animal models: Transgenic animal models for the study of measles pathogenesis

Current Topics in Microbiology and Immunology

Volumn 330, Issue , 2009, Pages 111-127

  Sellin, C I ^a   Horvat, B ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD150 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEASLES VACCINE; MEMBRANE COFACTOR PROTEIN; PROTEIN KINASE LCK;

ADAPTIVE IMMUNITY; ADENOVIRUS INFECTION; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; LYMPHOCYTE; MEASLES; MEASLES VIRUS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VIRUS CELL INTERACTION; VIRUS INDUCTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; DISEASE MODELS, ANIMAL; HUMANS; MEASLES; MEASLES VIRUS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS;

ADENOVIRIDAE; ANIMALIA; HUMAN HERPESVIRUS 6; MEASLES VIRUS; MUS;

EID: 58249116971     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-70617-5_6     Document Type: Review

References (55)

1. Andres O, Obojes K, Kim KS, ter Meulen V, Schneider-Schaulies J (2003) CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 84:1189-1197
2. Blixenkrone-Moller M, Bernard A, Bencsik A, Sixt N, Diamond LE, Logan JS, Wild TF (1998) Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249:238-248
3. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R (1998) A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J 17:3899-3908
4. Christiansen D, Devaux P, Reveil B, Evlashev A, Horvat B, Lamy J, Rabourdin-Combe C, Cohen JH, Gerlier D (2000) Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J Virol 74:4672-4678
5. Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F (2003) A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol 77:11546-11554
6. Despres P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F (2005) Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 191:207-214
7. DiPaolo N, Ni S, Gaggar A, Strauss R, Tuve S, Li ZY, Stone D, Shayakhmetov D, Kiviat N, Toure P et al (2006) Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination. Mol Ther 13:756-765
8. Dorig RE, Marcil A, Chopra A, Richardson CD (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305
9. Druelle J, Sellin CI, Waku-Kouomou D, Horvat B, Wild FT (2008) Wild type measles virus attenuation independent of type I IFN. Virol J 5:22
10. Evlashev A, Moyse E, Valentin H, Azocar O, Trescol-Biemont MC, Marie JC, Rabourdin-Combe C, Horvat B (2000) Productive measles virus brain infection and apoptosis in CD46 transgenic mice. J Virol 74:1373-1382
11. Evlashev A, Valentin H, Rivailler P, Azocar O, Rabourdin-Combe C, Horvat B (2001) Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes. J Gen Virol 82:2125-2129
12. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9:1408-1412
13. Hahm B, Arbour N, Naniche D, Homann D, Manchester M, Oldstone MB (2003) Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J Virol 77:3505-3515
14. Hahm B, Arbour N, Oldstone MB (2004) Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 323:292-302
15. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB (2005) Viruses evade the immune system through type I interferon-mediated STAT2-dependent but STAT1-independent signaling. Immunity 22:247-257
16. Hahm B, Cho JH, Oldstone MB (2007) Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 358:251-257
17. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y (2002) SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743-6749
18. Horvat B, Rivailler P, Varior-Krishnan G, Cardoso A, Gerlier D, Rabourdin-Combe C (1996) Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infection. J Virol 70:6673-6681
19. Kemper C, Leung M, Stephensen CB, Pinkert CA, Liszewski MK, Cattaneo R, Atkinson JP (2001) Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol 124:180-189
20. Kerdiles YM, Sellin CI, Druelle J, Horvat B (2006) Immunosuppression caused by measles virus: role of viral proteins. Rev Med Virol 16:49-63
21. Kouomou DW, Wild TF (2002) Adaptation of wild-type measles virus to tissue culture. J Virol 76:1505-1509
22. Lawrence DM, Vaughn MM, Belman AR, Cole JS, Rall GF (1999) Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol 73:1795-1801
23. Lawrence DM, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM, Rall GF (2000) Measles virus spread between neurons requires cell contact but not CD46 expression syncytium formation or extracellular virus production. J Virol 74:1908-1918
24. Lorin C, Mollet L, Delebecque F, Combredet C, Hurtrel B, Charneau P, Brahic M, Tangy F (2004) A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 78:146-157
25. Makhortova NR, Askovich P, Patterson CE, Gechman LA, Gerard NP, Rall GF (2007) Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 362:235-244
26. Manchester M, Eto DS, Oldstone MB (1999) Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice. J Neuroimmunol 96:207-217
27. Marie JC, Kehren J, Trescol-Biemont MC, Evlashev A, Valentin H, Walzer T, Tedone R, Loveland B, Nicolas JF, Rabourdin-Combe C, Horvat B (2001) Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 14:69-79
28. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 3:659-666
29. Mrkic B, Pavlovic J, Rulicke T, Volpe P, Buchholz CJ, Hourcade D, Atkinson JP, Aguzzi A, Cattaneo R (1998) Measles virus spread and pathogenesis in genetically modified mice. J Virol 72:7420-7427
30. Mrkic B, Odermatt B, Klein MA, Billeter MA, Pavlovic J, Cattaneo R (2000) Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol 74:1364-1372
31. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025-6032
32. Niewiesk S, Schneider-Schaulies J, Ohnimus H, Jassoy C, Schneider-Schaulies S, Diamond L, Logan JS, and ter Meulen V (1997) CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J Virol 71:7969-7973
33. Ohno S, Ono N, Seki F, Takeda M, Kura S, Tsuzuki T, Yanagi Y (2007) Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol 81:1650-1659
34. Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A (1999) Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98:629-640
35. Oldstone MB, Dales S, Tishon A, Lewicki H, Martin L (2005) A role for dual viral hits in causation of subacute sclerosing panencephalitis. J Exp Med 202:1185-1190
36. Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y (2001) V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol 75:1594-1600
37. Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB (2000) V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80-89
38. Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, Thomas D, Billeter MA, Oldstone MB (2001) Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291:215-225
39. Patterson CE, Lawrence DM, Echols LA, Rall GF (2002) Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76:4497-4506
40. Patterson CE, Daley JK, Echols LA, Lane TE, Rall GF (2003) Measles virus infection induces chemokine synthesis by neurons. J Immunol 171:3102-3109
41. Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ (2002) Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 62:4656-4662
42. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB (1997) A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A 94:4659-4663
43. Rivailler P, Trescol-Biemont MC, Gimenez C, Rabourdin-Combe C, Horvat B (1998) Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46. Eur J Immunol 28:1301-1314
44. Roscic-Mrkic B, Schwendener RA, Odermatt B, Zuniga A, Pavlovic J, Billeter MA, Cattaneo R (2001) Roles of macrophages in measles virus infection of genetically modified mice. J Virol 75:3343-3351
45. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827
46. Sellin CI, Davoust N, Guillaume V, Baas D, Belin MF, Buckland R, Wild TF, Horvat B (2006) High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol 80:6420-6429
47. Shingai M, Inoue N, Okuno T, Okabe M, Akazawa T, Miyamoto Y, Ayata M, Honda K, Kurita-Taniguchi M, Matsumoto M et al (2005) Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J Immunol 175:3252-3261
48. Slifka MK, Homann D, Tishon A, Pagarigan R, Oldstone MB (2003) Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J Clin Invest 111:805-810
49. Takeuchi K, Miyajima N, Nagata N, Takeda M, Tashiro M (2003) Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res 94:11-16
50. Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897
51. Thorley BR, Milland J, Christiansen D, Lanteri MB, McInnes B, Moeller I, Rivailler P, Horvat B, Rabourdin-Combe C, Gerlier D et al (1997) Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. Eur J Immunol 27:726-734
52. Tishon A, Lewicki H, Andaya A, McGavern D, Martin L, Oldstone MB (2006) CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4 CD8 or B cells alone are ineffective. Virology 347:234-245
53. Welstead GG, Iorio C, Draker R, Bayani J, Squire J, Vongpunsawad S, Cattaneo R, Richardson CD (2005) Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc Natl Acad Sci U S A 102:16415-16420
54. WHO (2002) Scaling up the response to infectious diseases. www.who.int/infectious-diseasereport/2002/introduction.html. Cited 26 May 2008
55. Yannoutsos N, Ijzermans JN, Harkes C, Bonthuis F, Zhou CY, White D, Marquet RL, Grosveld F (1996) A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells 1:409-419